(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CBR1 mRNA] CTD PMID:31150632 1,2-naphthoquinone multiple interactions ISO RGD:737546 6480464 [S-Nitrosoglutathione binds to CBR1 protein] promotes the reaction [CBR1 protein results in increased metabolism of 1, 2-naphthoquinone] CTD PMID:23295225 1,4-dithiothreitol multiple interactions ISO RGD:737546 6480464 Dithiothreitol inhibits the reaction [S-Nitrosoglutathione inhibits the reaction [CBR1 protein results in increased reduction of S-Nitrosoglutathione]] CTD PMID:21256830 1,4-naphthoquinone multiple interactions ISO RGD:737546 6480464 [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of 1, 4-naphthoquinone] CTD PMID:23295225 13-dihydrodaunorubicin multiple interactions ISO RGD:737546 6480464 [[Curcumin binds to and results in decreased activity of CBR1 protein] which results in decreased reduction of Daunorubicin] which results in decreased chemical synthesis of daunorubicinol more ... CTD PMID:20670211 , PMID:25541467 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of CBR1 mRNA CTD PMID:26496021 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CBR1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CBR1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CBR1 protein CTD PMID:19492234 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of CBR1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of CBR1 mRNA CTD PMID:21346803 2-amino-14,16-dimethyloctadecan-3-ol decreases expression ISO RGD:737546 6480464 2-amino-14, 16-dimethyloctadecan-3-ol results in decreased expression of CBR1 protein CTD PMID:32044396 2-hydroxypropanoic acid decreases expression ISO RGD:737546 6480464 Lactic Acid results in decreased expression of CBR1 mRNA CTD PMID:30851411 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO RGD:737546 6480464 Ethacrynic Acid inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] more ... CTD PMID:11306090 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases metabolic processing ISO RGD:737546 6480464 CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:11306090 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of CBR1 mRNA CTD PMID:21346803 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of CBR1 mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of CBR1 mRNA CTD PMID:19483382 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CBR1 mRNA CTD PMID:24780913 9,10-phenanthroquinone increases metabolic processing ISO RGD:737546 6480464 CBR1 protein results in increased metabolism of 9, 10-phenanthrenequinone CTD PMID:29108775 9,10-phenanthroquinone multiple interactions ISO RGD:737546 6480464 [CBR1 protein co-treated with NADP] results in increased reduction of and affects the activity of 9 more ... CTD PMID:21910479 , PMID:23295225 Aloe emodin decreases activity ISO RGD:737546 6480464 aloe emodin results in decreased activity of CBR1 protein CTD PMID:35065925 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of CBR1 mRNA CTD PMID:19483382 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CBR1 mRNA CTD PMID:16483693 antimonite multiple interactions ISO RGD:737546 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CBR1 mRNA CTD PMID:32076005 antimycin A decreases expression ISO RGD:737546 6480464 Antimycin A results in decreased expression of CBR1 mRNA CTD PMID:33512557 aristolochic acid increases expression ISO RGD:737546 6480464 aristolochic acid I results in increased expression of CBR1 protein CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:737546 6480464 [sodium arsenite results in increased abundance of arsenite] which results in increased expression of CBR1 mRNA more ... CTD PMID:32076005 , PMID:32406909 arsenous acid decreases response to substance ISO RGD:737546 6480464 CBR1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:22719067 arsenous acid increases expression ISO RGD:737546 6480464 Arsenic Trioxide results in increased expression of CBR1 mRNA CTD PMID:22719067 atrazine decreases expression ISO RGD:737546 6480464 Atrazine results in decreased expression of CBR1 mRNA CTD PMID:22378314 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of CBR1 mRNA CTD PMID:19483382 benzo[a]pyrene increases expression ISO RGD:737546 6480464 Benzo(a)pyrene results in increased expression of CBR1 mRNA, Benzo(a)pyrene results in increased expression of CBR1 protein CTD PMID:22531821 benzo[a]pyrene decreases methylation ISO RGD:737546 6480464 Benzo(a)pyrene results in decreased methylation of CBR1 exon CTD PMID:27901495 beta-naphthoflavone increases expression ISO RGD:737546 6480464 beta-Naphthoflavone results in increased expression of CBR1 mRNA CTD PMID:17569794 , PMID:19737606 bexarotene increases expression EXP 6480464 Bexarotene results in increased expression of CBR1 mRNA CTD PMID:16648578 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of CBR1 mRNA, [bisphenol A co-treated with Testosterone] results in increased expression of CBR1 mRNA CTD PMID:26496021 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CBR1 mRNA CTD PMID:25181051 butylated hydroxyanisole increases expression ISO RGD:737546 6480464 Butylated Hydroxyanisole results in increased expression of CBR1 mRNA, Butylated Hydroxyanisole results in increased expression of CBR1 protein CTD PMID:23247010 carbamazepine affects expression ISO RGD:737546 6480464 Carbamazepine affects the expression of CBR1 mRNA CTD PMID:24752500 CGP 52608 multiple interactions ISO RGD:737546 6480464 CGP 52608 promotes the reaction [RORA protein binds to CBR1 gene] CTD PMID:28238834 chenodeoxycholic acid multiple interactions ISO RGD:737546 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA, [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 cisplatin multiple interactions ISO RGD:737546 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of CBR1 mRNA CTD PMID:27392435 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of CBR1 mRNA CTD PMID:19483382 Clofop increases reduction ISO RGD:737546 6480464 CBR1 protein results in increased reduction of fenofibric acid CTD PMID:27599626 coumarin increases expression EXP 6480464 coumarin results in increased expression of CBR1 mRNA CTD PMID:18480146 coumestrol increases expression ISO RGD:737546 6480464 Coumestrol results in increased expression of CBR1 mRNA CTD PMID:19167446 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of CBR1 mRNA CTD PMID:26577399 curcumin multiple interactions ISO RGD:737546 6480464 [[Curcumin binds to and results in decreased activity of CBR1 protein] which results in decreased reduction of Daunorubicin] which results in decreased chemical synthesis of daunorubicinol more ... CTD PMID:25541467 cyclosporin A decreases expression ISO RGD:737546 6480464 Cyclosporine results in decreased expression of CBR1 mRNA CTD PMID:20106945 , PMID:25562108 cyclosporin A multiple interactions ISO RGD:737546 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 daunorubicin increases reduction ISO RGD:737546 6480464 CBR1 protein results in increased reduction of Daunorubicin CTD PMID:18579125 , PMID:25541467 daunorubicin decreases metabolic processing ISO RGD:737546 6480464 CBR1 gene SNP results in decreased metabolism of Daunorubicin CTD PMID:19204081 daunorubicin multiple interactions ISO RGD:737546 6480464 8-prenylnaringenin inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin] more ... CTD PMID:20670211 more ... daunorubicin increases metabolic processing ISO RGD:737546 6480464 CBR1 protein results in increased metabolism of Daunorubicin, CBR1 results in increased metabolism of Daunorubicin CTD PMID:20670211 , PMID:30849340 deguelin decreases expression ISO RGD:737546 6480464 deguelin results in decreased expression of CBR1 mRNA CTD PMID:33512557 deoxycholic acid multiple interactions ISO RGD:737546 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA, [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 diarsenic trioxide increases expression ISO RGD:737546 6480464 Arsenic Trioxide results in increased expression of CBR1 mRNA CTD PMID:22719067 diarsenic trioxide decreases response to substance ISO RGD:737546 6480464 CBR1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:22719067 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of CBR1 mRNA CTD PMID:21266533 diclofenac affects expression ISO RGD:737546 6480464 Diclofenac affects the expression of CBR1 mRNA CTD PMID:24752500 dioxygen multiple interactions ISO RGD:737546 6480464 3 more ... CTD PMID:24975222 dioxygen increases expression ISO RGD:737546 6480464 Oxygen deficiency results in increased expression of CBR1 mRNA, Oxygen deficiency results in increased expression of CBR1 protein CTD PMID:24975222 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions ISO RGD:737546 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CBR1 mRNA CTD PMID:32076005 diuron decreases expression EXP 6480464 Diuron results in decreased expression of CBR1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:737546 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CBR1 mRNA CTD PMID:27188386 doxorubicin increases expression ISO RGD:737546 6480464 Doxorubicin results in increased expression of CBR1 protein CTD PMID:18755171 doxorubicin affects reduction ISO RGD:737546 6480464 CBR1 protein affects the reduction of Doxorubicin CTD PMID:18635746 doxorubicin multiple interactions ISO RGD:737546 6480464 [Resveratrol results in decreased activity of CBR1 protein] which affects the susceptibility to Doxorubicin CTD PMID:24064738 doxorubicin increases reduction ISO RGD:737546 6480464 CBR1 protein results in increased reduction of Doxorubicin CTD PMID:18755171 doxorubicin decreases metabolic processing ISO RGD:737546 6480464 CBR1 gene SNP results in decreased metabolism of Doxorubicin CTD PMID:19204081 emodin decreases activity ISO RGD:737546 6480464 Emodin results in decreased activity of CBR1 protein CTD PMID:35065925 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of CBR1 mRNA CTD PMID:29391264 etacrynic acid multiple interactions ISO RGD:737546 6480464 Ethacrynic Acid inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] CTD PMID:11306090 fenpyroximate decreases expression ISO RGD:737546 6480464 fenpyroximate results in decreased expression of CBR1 mRNA CTD PMID:33512557 flutamide increases expression EXP 6480464 Flutamide results in increased expression of CBR1 mRNA CTD PMID:24136188 Frangulin A decreases activity ISO RGD:737546 6480464 frangulin A results in decreased activity of CBR1 protein CTD PMID:35065925 Frangulin B decreases activity ISO RGD:737546 6480464 frangulin B results in decreased activity of CBR1 protein CTD PMID:35065925 furan increases expression EXP 6480464 furan results in increased expression of CBR1 mRNA CTD PMID:25539665 genistein multiple interactions ISO RGD:737546 6480464 [Genistein co-treated with NADP] binds to CBR1 protein CTD PMID:25526675 genistein increases expression ISO RGD:737546 6480464 Genistein results in increased expression of CBR1 mRNA CTD PMID:16705744 glycochenodeoxycholic acid multiple interactions ISO RGD:737546 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA, [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 glycocholic acid multiple interactions ISO RGD:737546 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA, [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 glycodeoxycholic acid multiple interactions ISO RGD:737546 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA, [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 hexane-2,3-dione multiple interactions ISO RGD:737546 6480464 8-prenylnaringenin inhibits the reaction [CBR1 protein results in increased reduction of 2 more ... CTD PMID:23295225 more ... hexane-2,3-dione increases reduction ISO RGD:737546 6480464 CBR1 protein results in increased reduction of 2, 3-hexanedione CTD PMID:25541467 , PMID:30849340 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of CBR1 mRNA CTD PMID:18299717 isatin multiple interactions ISO RGD:737546 6480464 [S-Nitrosoglutathione binds to CBR1 protein] promotes the reaction [CBR1 protein results in increased metabolism of Isatin] CTD PMID:23295225 Isoxanthohumol multiple interactions ISO RGD:737546 6480464 isoxanthohumol inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin] more ... CTD PMID:30849340 Isoxanthohumol decreases activity ISO RGD:737546 6480464 isoxanthohumol results in decreased activity of CBR1 protein CTD PMID:35065925 ivermectin decreases expression ISO RGD:737546 6480464 Ivermectin results in decreased expression of CBR1 protein CTD PMID:32959892 L-1,4-dithiothreitol multiple interactions ISO RGD:737546 6480464 Dithiothreitol inhibits the reaction [S-Nitrosoglutathione inhibits the reaction [CBR1 protein results in increased reduction of S-Nitrosoglutathione]] CTD PMID:21256830 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of CBR1 mRNA CTD PMID:19483382 leflunomide increases expression EXP 6480464 Leflunomide results in increased expression of CBR1 mRNA CTD PMID:24136188 lipopolysaccharide multiple interactions ISO RGD:737546 6480464 CBR1 protein modified form inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] more ... CTD PMID:25818598 m-xylene increases expression EXP 6480464 3-xylene results in increased expression of CBR1 mRNA CTD PMID:12815608 menadione increases metabolic processing ISO RGD:737546 6480464 CBR1 protein results in increased metabolism of Vitamin K 3 CTD PMID:19061875 menadione multiple interactions ISO RGD:737546 6480464 [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of Vitamin K 3], Vitamin K 3 inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] CTD PMID:11306090 , PMID:23295225 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of CBR1 mRNA CTD PMID:15644446 methylmercury chloride decreases expression ISO RGD:737546 6480464 methylmercuric chloride results in decreased expression of CBR1 mRNA CTD PMID:27188386 N-methyl-N-nitrosourea increases expression EXP 6480464 Methylnitrosourea results in increased expression of CBR1 mRNA CTD PMID:16525678 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of CBR1 mRNA CTD PMID:19638242 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of CBR1 mRNA CTD PMID:19716841 NADP zwitterion multiple interactions ISO RGD:737546 6480464 [CBR1 protein co-treated with NADP] results in increased reduction of and affects the activity of 9 more ... CTD PMID:21910479 more ... NADP(+) multiple interactions ISO RGD:737546 6480464 [CBR1 protein co-treated with NADP] results in increased reduction of and affects the activity of 9 more ... CTD PMID:21910479 more ... naphthalenes increases expression EXP 6480464 Naphthalenes results in increased expression of CBR1 protein CTD PMID:17337753 naphthalenes multiple interactions ISO RGD:737546 6480464 [CBR1 protein co-treated with NADP] results in increased reduction of and affects the activity of Naphthalenes CTD PMID:21910479 nefazodone multiple interactions ISO RGD:737546 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CBR1 mRNA CTD PMID:32152650 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of CBR1 mRNA CTD PMID:24136188 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of CBR1 mRNA CTD PMID:24136188 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of CBR1 mRNA CTD PMID:19483382 oxcarbazepine increases reduction ISO RGD:737546 6480464 CBR1 protein results in increased reduction of Oxcarbazepine CTD PMID:25063510 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of CBR1 mRNA CTD PMID:18246545 paracetamol decreases expression ISO RGD:737546 6480464 Acetaminophen results in decreased expression of CBR1 mRNA CTD PMID:22230336 , PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CBR1 mRNA CTD PMID:18246545 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CBR1 mRNA CTD PMID:19162173 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:737546 6480464 CBR1 protein modified form inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL1B mRNA] more ... CTD PMID:25818598 phorone affects expression EXP 6480464 phorone affects the expression of CBR1 mRNA CTD PMID:18198479 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CBR1 mRNA CTD PMID:19162173 , PMID:22484513 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of CBR1 mRNA CTD PMID:19483382 potassium chromate increases expression ISO RGD:737546 6480464 potassium chromate(VI) results in increased expression of CBR1 mRNA CTD PMID:22714537 quercetin multiple interactions ISO RGD:737546 6480464 [Quercetin co-treated with NADP] binds to CBR1 protein more ... CTD PMID:11306090 more ... rac-lactic acid decreases expression ISO RGD:737546 6480464 Lactic Acid results in decreased expression of CBR1 mRNA CTD PMID:30851411 Rebamipide increases expression EXP 6480464 rebamipide results in increased expression of CBR1 mRNA CTD PMID:18299717 resveratrol multiple interactions ISO RGD:737546 6480464 [Resveratrol results in decreased activity of CBR1 protein] which affects the susceptibility to Doxorubicin more ... CTD PMID:24064738 , PMID:24975222 resveratrol affects binding ISO RGD:737546 6480464 CBR1 protein binds to Resveratrol CTD PMID:24064738 rotenone increases expression EXP 6480464 Rotenone results in increased expression of CBR1 mRNA CTD PMID:28374803 rutin multiple interactions ISO RGD:737546 6480464 Rutin binds to and results in decreased activity of CBR1 protein, Rutin inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] CTD PMID:11306090 , PMID:18579125 S-nitrosoglutathione multiple interactions ISO RGD:737546 6480464 [S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of 1 more ... CTD PMID:21256830 , PMID:23295225 S-nitrosoglutathione increases reduction ISO RGD:737546 6480464 CBR1 protein results in increased reduction of S-Nitrosoglutathione CTD PMID:21256830 SB 431542 multiple interactions ISO RGD:737546 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CBR1 mRNA CTD PMID:27188386 sodium arsenite multiple interactions ISO RGD:737546 6480464 [sodium arsenite results in increased abundance of arsenite] which results in increased expression of CBR1 mRNA CTD PMID:32076005 sodium arsenite increases expression ISO RGD:737546 6480464 sodium arsenite results in increased expression of CBR1 mRNA CTD PMID:28595984 , PMID:34032870 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CBR1 protein CTD PMID:29459688 sophoraflavanone B multiple interactions ISO RGD:737546 6480464 8-prenylnaringenin inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin] more ... CTD PMID:30849340 streptozocin decreases activity EXP 6480464 Streptozocin results in decreased activity of CBR1 protein CTD PMID:11057757 T-2 toxin affects expression EXP 6480464 T-2 Toxin affects the expression of CBR1 protein CTD PMID:26141394 tebufenpyrad decreases expression ISO RGD:737546 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of CBR1 mRNA CTD PMID:33512557 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of CBR1 mRNA CTD PMID:26496021 testosterone enanthate affects expression ISO RGD:737546 6480464 testosterone enanthate affects the expression of CBR1 mRNA CTD PMID:17440010 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CBR1 mRNA CTD PMID:30723492 , PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CBR1 mRNA] CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CBR1 mRNA CTD PMID:23411599 , PMID:34492290 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of CBR1 mRNA CTD PMID:19483382 tiaprofenic acid increases reduction ISO RGD:737546 6480464 CBR1 protein results in increased reduction of tiaprofenic acid CTD PMID:28322780 triclosan multiple interactions ISO RGD:737546 6480464 [Triclosan co-treated with NADP] binds to CBR1 protein CTD PMID:25526675 undecane increases expression EXP 6480464 undecane results in increased expression of CBR1 protein CTD PMID:17337753 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of CBR1 mRNA CTD PMID:24136188 valproic acid decreases methylation ISO RGD:737546 6480464 Valproic Acid results in decreased methylation of CBR1 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:737546 6480464 Valproic Acid results in increased expression of CBR1 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:737546 6480464 Valproic Acid affects the expression of CBR1 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:737546 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CBR1 mRNA CTD PMID:27188386 xanthohumol multiple interactions ISO RGD:737546 6480464 xanthohumol inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin] more ... CTD PMID:30849340 zoledronic acid decreases expression ISO RGD:737546 6480464 Zoledronic Acid results in decreased expression of CBR1 mRNA CTD PMID:24714768
